|Articles|September 2, 2021

Pii Hires Roberto Almodóvar Febles as Head of Aseptic Operations

Febles will oversee day-to-day aseptic manufacturing at Pharmaceutics International, Inc.

PharmaceuticsInternational, Inc. (Pii) announced in an Aug. 31, 2021 press release that Roberto Almodóvar Febles has been hired as their Head of Aseptic Operations. In this role, Febles will oversee and manage day-to-day aseptic manufacturing. He will work closely with Sam Chia, the head of aseptic manufacturing science and technology, as well as the operations leadership team members.

Prior to joining Pii, Febles worked with Baxter Healthcare, Amgen, iPR Pharmaceuticals (the CMO for AstraZeneca), and Mylan. He earned a Bachelors of Science in both Chemistry and Chemical Engineering at the University of Puerto Rico, Mayagüez Campus, and an Executive Master degree in Business Administration from the Interamerican University of Puerto Rico, Cupey Campus.

“Roberto is an experienced manufacturing leader with more than 15 years of progressive experience in aseptic manufacturing as an operator, supervisor, and manager,” said Kurt Nielsen, CEO of Pii, in a company press release. “I am confident Roberto and the other teams will work to successfully deliver on-time, and right first time, for our clients."

Source: Pharmaceutics International, Inc.


Related to this article

Stainless steel bioreactor vessels in a manufacturing facility. | Image Credit: © Corona Borealis - stock.adobe.com
Four cell therapy developers have pulled back from ex vivo manufacturing in the past month — ArsenalBio, TScan Therapeutics, and Cellectis all pivoted to in vivo approaches, while Bristol Myers Squibb terminated its manufacturing partnership with automation specialist Cellares after determining its platform couldn't meet requirements for commercial Breyanzi production, triggering layoffs.